LAG3 and neoplasm: Similar to CD4, LAG-3 binds to major histocompatibility complex II (MHC II) to negatively regulate T cells, maintain immune system homeostasis, and promote tumor immune escape (Figure 2), but with a much stronger affinity to CD4 (4, 16).